Source:http://linkedlifedata.com/resource/pubmed/id/21342058
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-2-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1744-8336
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-41
|
pubmed:meshHeading |
pubmed-meshheading:21342058-Anti-Bacterial Agents,
pubmed-meshheading:21342058-Carbapenems,
pubmed-meshheading:21342058-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:21342058-Enterobacteriaceae,
pubmed-meshheading:21342058-Enterobacteriaceae Infections,
pubmed-meshheading:21342058-Humans,
pubmed-meshheading:21342058-India,
pubmed-meshheading:21342058-Microbial Sensitivity Tests,
pubmed-meshheading:21342058-beta-Lactamases
|
pubmed:year |
2011
|
pubmed:articleTitle |
The new medical challenge: why NDM-1? Why Indian?
|
pubmed:publicationType |
Editorial
|